金城医药：预计2025年净利润同比下降73.07%-79.67%

Core Viewpoint - Jincheng Pharmaceutical expects a significant decline in net profit for the fiscal year 2025, projecting a decrease of 73.07% to 79.67% compared to the previous year [1] Financial Projections - The net profit attributable to shareholders is estimated to be between 40 million to 53 million yuan [1] - The net profit after deducting non-recurring gains and losses is projected to be between 28 million to 37 million yuan, reflecting a decline of 79.43% to 84.44% year-on-year [1] - The impact of non-recurring gains and losses on net profit is estimated to be between 12 million to 16 million yuan [1]